Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1718 studies found for:    Multiple Sclerosis
Show Display Options
Rank Status Study
21 Terminated Imaging Multiple Sclerosis Lesions Using Magnevist and Gadavist
Condition: Multiple Sclerosis
Intervention:
22 Completed Patient Research Cohort: Rapidly Evolving Multiple Sclerosis
Conditions: Relapsing-remitting Multiple Sclerosis;   Secondary Progressive Multiple Sclerosis
Intervention:
23 Completed
Has Results
A Safety and Efficacy Study of CNTO1275 in Patients With Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: CNTO 1275
24 Active, not recruiting Allogeneic Stem Cell Transplantation for the Treatment of Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Biological: FCRx infusion
25 Not yet recruiting Comparison Between Clinical and MRI Multiple Sclerosis Activity and Expression of Human Endogenous Retrovirus Type W and Herpesvirus
Condition: Multiple Sclerosis
Intervention:
26 Completed Supported Treadmill Training for Progressive Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Other: Body-weight supported treadmill training
27 Completed
Has Results
REbif FLEXible Dosing in Early Multiple Sclerosis (MS)
Condition: Multiple Sclerosis
Interventions: Drug: RNF;   Drug: Placebo
28 Recruiting Correlation Between the 'Nine Holes Peg Test' Performance and the Triple Stimulation Technique Within a Group a Patients With Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Other: Nine Hole Test;   Device: Triple Stimulation Technique
29 Active, not recruiting Improving Hand Use in Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Behavioral: CI Therapy;   Behavioral: CAM treatments
30 Terminated Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks
Condition: Multiple Sclerosis
Interventions: Drug: megadose oral methylprednisolone;   Drug: IV methylprednisolone
31 Terminated High Dose Chemo With Stem Cell Transplant as Treatment for Multiple Sclerosis That Failed Prior Treatment
Condition: Multiple Sclerosis
Interventions: Drug: Alemtuzumab;   Drug: Fludarabine;   Drug: Cyclophosphamide
32 Completed Safety and Immunologic Effect of Low Dose Versus High Dose Vitamin D3 in Multiple Sclerosis
Conditions: Multiple Sclerosis;   Vitamin D Deficiency
Intervention: Drug: Cholecalciferol
33 Unknown  Tolerability of Acthar for the Treatment of Multiple Sclerosis in Relapses (TAMS)
Condition: Relapsing Remitting Multiple Sclerosis
Intervention: Drug: Acthar
34 Completed Nanotechnology for Detection of Multiple Sclerosis Compared to Autoimmune and Neurological Diseases by Exhaled Samples
Condition: Multiple Sclerosis
Intervention: Other: NA-NOSE artificial olfactory system
35 Recruiting Swiss Multiple Sclerosis Registry
Condition: Multiple Sclerosis
Intervention:
36 Recruiting Intensity Depended Impacts on Cognitive Functions in Persons With Multiple Sclerosis - a Pilot Study
Condition: Multiple Sclerosis
Interventions: Behavioral: Exercise;   Behavioral: Relaxation
37 Completed Effects of Meditation on Multiple Sclerosis and Peripheral Neuropathy
Conditions: Multiple Sclerosis;   Peripheral Neuropathy
Intervention: Behavioral: Meditation instruction and practice
38 Completed
Has Results
Evaluate Early Glatiramer Acetate Treatment in Delaying Conversion to Clinically Definite Multiple Sclerosis of Subjects Presenting With Clinically Isolated Syndrome
Condition: Multiple Sclerosis
Interventions: Drug: Glatiramer Acetate (DB);   Drug: Placebo;   Drug: Glatiramer Acetate (OL)
39 Completed Preliminary Study for Selective Detection of the CD8+ Myelin Specific T Cell in the Blood of Multiple Sclerosis Patients
Condition: Multiple Sclerosis
Intervention: Biological: Blood samples
40 Recruiting Evaluation of Coagulation in Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.